Jeeva Clinical Trials Inc

03/13/2026

Pharma USA 2026 is bringing together pharmaceutical leaders and innovators to discuss the future of the industry.

We’re pleased to share that Harsha Rajasimha, Ph.D., our Founder & CEO, will be attending this premier cross-functional pharma gathering.

📅 March 16–17, 2026
📍 Philadelphia, PA, USA

The event provides an opportunity to connect with industry experts, explore emerging strategies, and discuss innovations shaping the future of drug development.

At Jeeva Clinical Trials, we remain committed to advancing AI-powered digital infrastructure that supports faster, more efficient, and patient-centric clinical trials worldwide.

We look forward to engaging with peers, partners, and innovators during the event.

🔗 Register now: https://hubs.la/Q046Hz1j0

03/12/2026

Patient recruitment is often the biggest bottleneck in clinical trials. When supported by the right technology, the entire process becomes faster, more coordinated, and easier for both patients and study teams.

Jeeva’s TRIALMAGNET™ platform helps sponsors, CROs, and sites streamline recruitment with automation, centralized coordination, and flexible workflows, making it easier to identify, screen, and enroll the right participants efficiently.

Accelerate enrollment and keep your trials moving forward.
👉 Request a demo: https://hubs.la/Q046tVt_0

03/09/2026

Clinical research today still depends on multiple disconnected tools and manual processes, making trial management complex for sponsors, CROs, clinical sites, and patients. As trials become more global and data-driven, the need for a more unified and intelligent approach is becoming increasingly clear.

Jeeva Clinical Trials is working to address this challenge through its patent-pending Unified AI-Embedded Platform, designed to bring fragmented trial processes together into one streamlined system. The goal is to simplify operations, strengthen collaboration across stakeholders, and support more efficient, patient-focused clinical research.

In this video, Harsha Karur Rajasimha, Founder & CEO of Jeeva Clinical Trials Inc, shares insights on how innovation and AI-driven platforms can help modernize clinical trial infrastructure and improve the way research is conducted.

▶️ Watch the full video here: https://youtu.be/m3ud1ZG6EXA

CAI Startups

03/08/2026

On this International Women’s Day, Jeeva Clinical Trials proudly celebrates the strength, dedication, and impact of women across every field, especially in clinical research.

From advancing innovation to improving patient outcomes, women continue to shape the future of healthcare with leadership, compassion, and vision. ✨

At Jeeva Clinical Trials Inc., we remain committed to supporting greater inclusivity, expanding research accessibility, and championing women’s health through our AI-powered digital clinical trial platform.

Together, we celebrate progress, inspire change, and support a future where women’s voices and health needs are always valued. 💜

03/06/2026

Rare Disease Day 2026 – From Washington DC to Global Action 🌍

Honored to join Rare Disease Day events across DC and globally, uniting policymakers, clinicians, patient advocates, and innovators to advance care for 300M+ living with rare diseases.

Key highlights included HHS & FDA dialogues on transformative regulatory pathways, Capitol Hill discussions with EveryLife Foundation, NIH sessions launching RDCRN 5, PaVe-GT Program, BGTC updates, and GARD’s AI trial matching.

Celebrating at , Dr. James Levine highlighted 5 major gaps in rare disease care and strategies to close them through collaboration, innovative funding, and regulatory engagement.

The message is clear: Rare diseases are not rare. Fragmentation is the enemy. Collaboration is the cure.

We remain committed to AI-enabled, cross-border solutions to accelerate gene & cell therapy and expand global access.

03/05/2026

🚀 Rare diseases may be individually uncommon, but collectively, they impact millions.

In conversation with Linord Rachel Moudou, Voice of America, Harsha K. Rajasimha, Ph.D., our founder & CEO shares why equitable representation in Clinical Trials remains one of the most critical challenges in healthcare, especially for children and underserved communities.

At Jeeva Clinical Trials, we believe innovation must go beyond speed and efficiency.
It must expand access, strengthen advocacy, and make inclusion foundational to research design.

Because the future of Clinical Trials isn’t just decentralized, it’s equitable.
👉 Watch the full conversation.

03/03/2026

We’re excited to share that our Founder & CEO, Harsha Rajasimha, Ph.D., will be attending LSX Investival Showcase USA 2026 in Miami.

📅 March 10–11, 2026
📍 Miami Beach Convention Center, FL, USA

This premier gathering brings together biotech, medtech, and digital health innovators with global investors and strategic partners, fostering meaningful conversations that shape the future of healthcare.

At Jeeva Clinical Trials, we continue advancing AI-powered digital clinical trial infrastructure to accelerate innovation and improve research outcomes worldwide.

We look forward to engaging with industry leaders and innovators in Miami.
🔗 Learn more & register: https://informaconnect.com/investival-showcase-usa/

03/02/2026

A defining step forward in our innovation journey.

Jeeva Clinical Trials has submitted a non-provisional utility patent application to the USPTO, reinforcing our commitment to building intelligent, AI-driven infrastructure for modern clinical research.

By embedding smart automation directly into a unified digital ecosystem, we aim to simplify operations, enhance data intelligence, and accelerate trial ex*****on, all within a single connected framework.

The next evolution of digital trials is underway.

03/01/2026

02/28/2026

🎗️ Honoring Rare Voices on Rare Disease Day 🎗️

Today, we recognize the resilience of patients, families, and researchers navigating the challenges of Rare Diseases. Their journeys inspire innovation, collaboration, and hope in every corner of the Rare Disease Community.

At Jeeva Clinical Trials, we aim to make these journeys a little smoother, connecting patients to trials, supporting complex data needs, and accelerating research that reaches communities across the globe.

Because in Rare Disease Research, every patient counts, every insight matters, and every step forward brings hope closer.

Discover how Jeeva is advancing Rare Disease Trials:
https://jeevatrials.com/therapeutic-areas/rare-disease/

02/25/2026

📰 Press Release Update

AI is advancing rapidly in drug development, but legacy infrastructure is holding the industry back.

Jeeva Clinical Trials Inc is calling on global life sciences leaders to modernize the foundation beneath AI. Without unified, cloud-native, regulatory-grade systems, innovation risks amplifying inefficiency instead of accelerating patient impact.

The future of AI-driven clinical trials depends on infrastructure built for intelligence from day one.

🔗 Read the full release to learn why modernization is now a strategic imperative.
https://www.einpresswire.com/article/895068810/jeeva-clinical-trials-calls-on-global-life-sciences-leaders-to-modernize-infrastructure-for-ai-driven-drug-development

02/23/2026

Jeeva Clinical Trials is honored to be part of Advanced Therapies Week 2026 at the San Diego Convention Center, where our Founder & CEO, Harsha Rajasimha, Ph.D., connected with global leaders advancing innovation in cell and gene therapy.

The event brought together pioneers across biotech, life sciences, and clinical research to exchange insights, explore emerging trends, and strengthen collaborations focused on advancing patient-centric therapies.

We value these opportunities to engage with the broader research community and reinforce Jeeva’s commitment to accelerating clinical trials through decentralized, patient-focused solutions.